Menüü

Otsi

SARS-CoV-2 Nucleocapsid protein Omicron (B.1.1.529)

SARS-CoV-2 Nucleocapsid protein Omicron (B.1.1.529)  

Figure 1. Simply Blue Safe Stain SDS-PAGE analysis of SARS-CoV-2 Nucleocapsid protein Omicron (B.1.1.529). 4-15% gradient gel is used for analysis. Lane 1. 0.8 µg SARS-CoV-2 Nucleocapsid protein Omicron (B.1.1.529) (-DTT). Lane 2. Protein marker (Smobio). Lane 3. 0.8 µg SARS-CoV-2 Nucleocapsid protein Omicron (B.1.1.529) (+DTT).

      SARS-CoV-2 Nucleocapsid protein Omicron (B.1.1.529)  

Figure 2. HPLC analytical SEC for final product.

      SARS-CoV-2 Nucleocapsid protein Omicron (B.1.1.529)  

Figure 3. HPLC analytical SEC after 3 freeze-thaw cycles.

Select volume:

Quantity:

€ 1650

Catalogue #

P-364-100

Name

SARS-CoV-2 Nucleocapsid protein Omicron (B.1.1.529)

Description

Protein contains amino acid changes R203K, G204R, P13L ja del31-33. Plus two extra amino acids (AS) in N-terminus and His-6 tag at C-terminus in the protein and GSG linker between protein and tag.

Uniprot ID

P0DTC9

MW

46.3 kDa

Host

CHO-based cell line (expressed by QMCF Technology)

Purification

Purified by Ni-affinity chromatography and gel-filtration from serum-free CHO growth media, sterile filtrated

Concentration

1 mg/ml

Buffer

PBS pH 7.4

Endotoxine

NA

QC

SDS-PAGE, NanoDrop A280, Analytical SEC

Shipping

Shipped on dry ice.

Storage

Store at -70°C upon receipt. Recommended to aliquot into smaller quantities. Avoid repeated freeze-thaw cycles

This product is for research use only

TECHNICAL ASSISTANCE

Please refer any technical questions to

technical.support@icosagen.com

Meie asukoht

Ameerika Ühendriikide kontor

77 Geary St. 5th Floor
San Francisco, CA 94108
+1 415 548 6625

Eesti kontor

Eerika tee 1
Õssu, Kambja vald
Tartu maakond 61713
Estonia
+372 737 7070
Shopping Cart